1. 1) Feng J, Li F, Zhao Y, Feng Y, Abe Y. Brain pharmacokinetics of tetramethylpyrazine after intranasal and intravenous administration in awake rats. Int. J. Pharm., 375, 55–60 (2009).
2. Pharmacokinetics of tetramethylpyrazine in rat blood and brain using microdialysis
3. 3) Hintz KK, Ren J. Tetramethylpyrazine elicits disparate responses in cardiac contraction and intracellular Ca2+ transients in isolated adult rat ventricular myocytes. Vascul. Pharmacol., 40, 213–217 (2003).
4. 4) Li M, Handa S, Ikeda Y, Goto S. Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine ‘Chuanxiong,’ on platelet thrombus formation under high shear rates. Thromb. Res., 104, 15–28 (2001).
5. 5) Sheu JR, Kan YC, Hung WC, Ko WC, Yen MH. Mechanisms involved in the antiplatelet activity of tetramethylpyrazine in human platelets. Thromb. Res., 88, 259–270 (1997).